V.1. Gastrin-releasing peptide receptor activation: role of cAMP. GRP-R activation results in both increases in cAMP and phospholipase C (PLC). The mGRP-R stably transfected into BALB-3T3 cells behaved in an identical fashion to the wild type on Swiss 3T3 cells, for binding, G-protein coupling, PLC activation and receptor modulation (internalization, down- regulation, desensitization), however it did not cause increases in cAMP, growth or c-fos mRNA. Detailed studies of both cell types demonstrate increases in cAMP do not mediate GRP-R modulation, but are important in bombesin-induced growth. V.2. Role of calcium in pepsinogen secretion. To define the roles of [Ca2+] in pepsinogen release, the effects of thapsigargin, CCK and secretin were compared in dispersed chief cells. Our results demonstrate that: 1) increases in [Ca2+]i due to Ca2+ influx caused by TG or CCK-8 can result in pepsinogen secretion. 2) mobilization of Ca2+ from intracellular sources is important in the rapid initial phase of pepsinogen secretion caused by CCK-8 and 3) the increase in [Ca2] per se whether caused by mobilization from [Ca2+]i stores or Ca2+ influx, is responsible for CCK-8 or TG potentiating secretin-stimulated pepsinogen release. V.3. Action of somatostatin (SS) on chief cells. We demonstrated for the first time that chief cells possess high affinity SS receptors likely of the SSTR/l subtype by binding studies. SS receptor occupation was regulated by agents that activate PKC or adenylate cyclase. SS receptor activation decreased the activity of adenylate cyclase but had no effect on pepsinogen release by various secretagogues. V.4. Distinguishing multiple CCK receptor subtypes. Using dispersed guinea pig chief cells and COS-7 cells transiently transfected with human hCCK/A-R or hCCK/B-R, recently described CCK receptor subtype selective agonists and antagonists are demonstrated to be useful in both species for distinguishing the role of each CCK receptor subtype in different physiological processes. V.5. Subtype of CCK receptor mediating CCK-induced pancreatic growth. CCK stimulates carcinogen-induced tumor formation and growth of the pancreas. In collaboration with Drs. R.H. Bell, Univ. of Cincinnati, and D.S. Longnecker, Dartmouth Medical School, the question of which subtype of CCK receptor mediated these effects was addressed. The results demonstrate CCK interaction with CCK/A receptors, not CCK/B receptors, mediate this pancreatic growth effect in vivo.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
González, Nieves; Mantey, Samuel A; Pradhan, Tapas K et al. (2009) Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. Peptides 30:1473-86
Gonzalez, Nieves; Nakagawa, Tomoo; Mantey, Samuel A et al. (2009) Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor. J Pharmacol Exp Ther 331:265-76
Gonzalez, Nieves; Moody, Terry W; Igarashi, Hisato et al. (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15:58-64
Jensen, R T; Battey, J F; Spindel, E R et al. (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42
Gonzalez, Nieves; Hocart, Simon J; Portal-Nunez, Sergio et al. (2008) Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor. J Pharmacol Exp Ther 324:463-74
Berna, Marc J; Jensen, Robert T (2007) Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem 7:1211-31
Moody, Terry W; Mantey, Samuel A; Fuselier, Joseph A et al. (2007) Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Peptides 28:1883-90
Berna, Marc J; Tapia, Jose A; Sancho, Veronica et al. (2007) Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential. Curr Opin Pharmacol 7:583-92
Berna, Marc J; Hoffmann, K Martin; Tapia, Jose A et al. (2007) CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim Biophys Acta 1773:483-501
Corleto, V D; Severi, C; Romano, G et al. (2006) Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil 18:217-25

Showing the most recent 10 out of 27 publications